FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely endocrinology, cardiology and can be used for treating dislipidemia. That is ensured by introducing a pharmaceutical composition containing a thiazolidinedione analogue of formula 
EFFECT: introducing the compound of formula 1 having decreased binding and activation of PPAR-gamma nuclear transcription factor, enables effective treatment of dislipidemia with no adverse side effects typical for PPAR-gamma agonists.
2 dwg, 5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
| PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
| NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
| HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
| HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2012 |
|
RU2608610C2 |
| PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
| MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
